[WATRMC 2018] What are the remaining challenges in the field of cell culture?

In this interview, filmed at the World Advanced Therapies and Regenerative Medicine Congress (16–18 May, London, UK), Hatim Hemeda, CEO, PL Bioscience, discusses the importance of xeno-free cell culture media.

Go to the profile of RegMedNet
May 17, 2018
0
0
Like 0 Comment

As part of the World Advanced Therapies and Regenerative Medicine Congress (16–18 May, London, UK) Interview Zone, RegMedNet Editor Freya Leask spoke to Hatim Hemeda, CEO, PL Bioscience (Germany). In this interview, Hatim discusses the importance of a characterized, xeno-free cell culture media in the development of an advanced therapy.

Find out more about the World Advanced Therapies and Regenerative Medicine Congress on their website.

Go to the profile of RegMedNet

RegMedNet

eCommunity, Future Science Group

RegMedNet is a networking site where users can share their knowledge and insights. This profile will share some content and updates from the RegMedNet team, including webinars, news and journal articles.

No comments yet.